Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22,042 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Turning Cold into Hot: Firing up the Tumor Microenvironment.
Duan Q, Zhang H, Zheng J, Zhang L. Duan Q, et al. Among authors: zheng j. Trends Cancer. 2020 Jul;6(7):605-618. doi: 10.1016/j.trecan.2020.02.022. Epub 2020 Mar 21. Trends Cancer. 2020. PMID: 32610070 Review.
CRISPR screen in mechanism and target discovery for cancer immunotherapy.
Liu D, Zhao X, Tang A, Xu X, Liu S, Zha L, Ma W, Zheng J, Shi M. Liu D, et al. Among authors: zheng j. Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188378. doi: 10.1016/j.bbcan.2020.188378. Epub 2020 May 13. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32413572 Review.
The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β.
Wang G, Zhou X, Guo Z, Huang N, Li J, Lv Y, Han L, Zheng W, Xu D, Chai D, Li H, Li L, Zheng J. Wang G, et al. Among authors: zheng w, zheng j. Cancer Biol Ther. 2022 Dec 31;23(1):150-162. doi: 10.1080/15384047.2022.2035629. Cancer Biol Ther. 2022. PMID: 35130111 Free PMC article.
22,042 results
You have reached the last available page of results. Please see the User Guide for more information.